Calendar
April 14, 2026 - Annual General Meeting
April 16, 2026 - van Lanschot Kempen Life Sciences Conference (Amsterdam)
April 29, 2026 (7:00am CEST) - Interim Report Q1 2026
Investors
Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: [email protected]
